U.S. stocks could face near-term pressure if the Federal Reserve resumes raising interest rates, even as corporate earnings ...
Palantir must achieve ~$42B in revenue and a 61% FCF margin by 2030 to justify its current valuation. See why I rate PLTR ...
Nigel Farage has survived plenty of political curveballs over the years, from milkshake attacks to reality-TV stunts. His ...
Ecolab Inc. closed the CoolIT acquisition early and reset FY2026 EPS guidance to $8.03–$8.23, below consensus. See why I rate ...
Occidental Petroleum upgraded: improved capital efficiency, deleveraging, and higher oil-price outlook—plus key risks. Click ...
Volkswagen CEO Oliver Blume targets cost cuts without plant closures amid restructuring and China competition.
You can manage investing emotions and build market cash flow with the Income Method. Discover top reliable income picks ...
Initiating Helus Pharma with a speculative Buy ahead of Q4 2026 Phase 3 APPROACH readout; undervalued HLP003 MDD asset offers ...
PACS Group shows rising margins and aggressive facility acquisitions, but governance/regulatory risks persist. Click for more ...
CDS spreads are widening for hyperscalers and chip giants, signaling rising credit risk and AI investment cycle uncertainty.
SK hynix’s US ADR debut spotlights HBM leadership and AI demand—yet warns of valuation gaps and peak risks. Read more on what ...
Almost 90% of Longleaf Partners Fund’s relative underperformance in the quarter came from our underweight in Information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results